Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oncology Institute (DFPH) Interest & Investment Income (2020 - 2023)

Historic Interest & Investment Income for Oncology Institute (DFPH) over the last 3 years, with Q3 2023 value amounting to $940000.0.

  • Oncology Institute's Interest & Investment Income changed N/A to $940000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $3.2 million, marking a year-over-year increase of 5476374.61%. This contributed to the annual value of $254149.0 for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q3 2023, Oncology Institute's Interest & Investment Income is $940000.0.
  • In the past 5 years, Oncology Institute's Interest & Investment Income ranged from a high of $1.2 million in Q1 2023 and a low of $5798.0 during Q3 2021
  • Its 3-year average for Interest & Investment Income is $425622.6, with a median of $76108.0 in 2020.
  • Over the last 5 years, Oncology Institute's Interest & Investment Income had its largest YoY gain of 9147.58% in 2021, and its largest YoY loss of 9210.01% in 2021.
  • Oncology Institute's Interest & Investment Income (Quarter) stood at $59248.0 in 2020, then plummeted by 90.21% to $5798.0 in 2021, then skyrocketed by 16112.49% to $940000.0 in 2023.
  • Its last three reported values are $940000.0 in Q3 2023, $1.0 million for Q2 2023, and $1.2 million during Q1 2023.